0.2520
22-November-24 15:44:58
15 minutes delayed
Stocks
-0.0040
-1.56%
Today's range
0.2435 - 0.2684
ISIN
N/A
Source
NASDAQ
Vincerx Pharma Presents Data on PTEFb/CDK9 Inhibitor VIP152 in DLBCL and CLL at the 63rd American Society of Hematology Annual Meeting
11 Dec 2021 14:30:00 By Nasdaq GlobeNewswire
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma
07 Dec 2021 07:00:01 By Nasdaq GlobeNewswire